Literature DB >> 1963042

(S)-1-(3-hydroxy-2-(phosphonylmethoxy)propyl)cytosine (HPMPC): a potent antiherpesvirus agent.

J J Bronson1, L M Ferrara, M J Hitchcock, H T Ho, K L Woods, I Ghazzouli, E R Kern, K F Soike, J C Martin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 1963042     DOI： 10.1007/978-1-4684-5853-4_28

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN： 0065-2598            Impact factor:   2.622


× No keyword cloud information.
  7 in total

1.  Determination of cidofovir in human plasma after low dose drug administration using high-performance liquid chromatography-tandem mass spectrometry.

Authors:  Jeremiah D Momper; Shimin Zhang; Parmjeet S Randhawa; Ron Shapiro; Kristine S Schonder; Raman Venkataramanan
Journal:  J Pharm Biomed Anal       Date:  2010-07-06       Impact factor: 3.935

2.  Single-dose pharmacokinetics of cidofovir in continuous venovenous hemofiltration.

Authors:  Matthias G Vossen; Klaus-Bernhard Gattringer; Walter Jäger; Stefanie Kraff; Florian Thalhammer
Journal:  Antimicrob Agents Chemother       Date:  2014-01-13       Impact factor: 5.191

3.  Pharmacokinetics of low-dose cidofovir in kidney transplant recipients with BK virus infection.

Authors:  J D Momper; Y Zhao; R Shapiro; K S Schonder; Y Gao; P S Randhawa; R Venkataramanan
Journal:  Transpl Infect Dis       Date:  2012-10-02       Impact factor: 2.228

Review 4.  Clinical pharmacokinetics of the antiviral nucleotide analogues cidofovir and adefovir.

Authors:  K C Cundy
Journal:  Clin Pharmacokinet       Date:  1999-02       Impact factor: 6.447

Review 5.  A review of antiviral drugs and other compounds with activity against feline herpesvirus type 1.

Authors:  Sara M Thomasy; David J Maggs
Journal:  Vet Ophthalmol       Date:  2016-04-19       Impact factor: 1.644

6.  Clinical pharmacokinetics of 1-[((S)-2-hydroxy-2-oxo-1,4,2-dioxaphosphorinan-5-yl)methyl]cytosine in human immunodeficiency virus-infected patients.

Authors:  K C Cundy; P Barditch-Crovo; B G Petty; A Ruby; M Redpath; H S Jaffe; P S Lietman
Journal:  Antimicrob Agents Chemother       Date:  1999-02       Impact factor: 5.191

7.  An orally bioavailable antipoxvirus compound (ST-246) inhibits extracellular virus formation and protects mice from lethal orthopoxvirus Challenge.

Authors:  Guang Yang; Daniel C Pevear; Marc H Davies; Marc S Collett; Tom Bailey; Susan Rippen; Linda Barone; Chris Burns; Gerry Rhodes; Sanjeev Tohan; John W Huggins; Robert O Baker; R L Mark Buller; Erin Touchette; Kem Waller; Jill Schriewer; Johan Neyts; Erik DeClercq; Kevin Jones; Dennis Hruby; Robert Jordan
Journal:  J Virol       Date:  2005-10       Impact factor: 6.549
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.